Artificial intelligence–assisted controlled ovarian stimulation in in vitro fertilization: A critical narrative review
International Journal of Gynecology & Obstetrics · 2026-12 · 175 (3) · 1242-1249
DOI: 10.1002/ijgo.71163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 19.06.2026. Verfasst von E Deligeoroglou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, 1st Department of Obstetrics and Gynecology, "Papageorgiou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Gre…. Hauptthemen laut MEDLINE: Ovulation Induction, Fertilization in Vitro, Artificial Intelligence. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Artificial intelligence (AI) is increasingly being investigated as a decision‐support tool in controlled ovarian stimulation (COS) during in vitro fertilization. Machine learning and deep learning algorithms have demonstrated promising predictive performance for outcomes including ovarian response, mature oocyte yield, premature luteinizing hormone rise, gonadotropin dose adjustment, and optimization of trigger timing. Convolutional neural networks applied to three‐dimensional ultrasound imaging have also enabled automated follicular monitoring and more standardized assessment of follicular development. This narrative review summarizes current AI applications in COS and critically evaluates the methodological quality, validation status, and clinical relevance of available models. Most published studies are retrospective and based on single‐center data sets, with limited external validation and scarce prospective randomized evidence. Furthermore, many reported improvements relate primarily to surrogate laboratory outcomes rather than clinically meaningful endpoints such as live birth rates. Although AI‐assisted COS demonstrates considerable potential for individualized treatment and workflow optimization, important barriers remain, including model interpretability, generalizability, ethical considerations, data privacy, and regulatory oversight. Future progress will require multicenter collaborations, prospective clinical validation, explainable AI frameworks, and careful integration of AI tools into clinician‐guided reproductive care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical School, 1st Department of Obstetrics and Gynecology, "Papageorgiou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- HYGEIA IVF Embryogenesis, Athens, Greece.
- Royal Surrey Country Hospital, Royal Surrey NHS Foundation Trust, Guildford, UK.
- Medical School, University of Nicosia, Nicosia, Cyprus.
ORCID-Profile: E Deligeoroglou
Zitieren
APA
Deligeoroglou, E., Makrakis, G., & Makrakis, E. (2026). Artificial intelligence–assisted controlled ovarian stimulation in in vitro fertilization: A critical narrative review. International Journal of Gynecology & Obstetrics, 175(3), 1242-1249. https://doi.org/10.1002/ijgo.71163
Vancouver
Deligeoroglou E, Makrakis G, Makrakis E. Artificial intelligence–assisted controlled ovarian stimulation in in vitro fertilization: A critical narrative review. International Journal of Gynecology & Obstetrics. 2026;175(3):1242-1249. doi:10.1002/ijgo.71163
BibTeX
@article{Deligeoroglou2026,
author = {Deligeoroglou, E and Makrakis, G and Makrakis, E},
title = {Artificial intelligence–assisted controlled ovarian stimulation in in vitro fertilization: A critical narrative review},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {175},
number = {3},
pages = {1242--1249},
doi = {10.1002/ijgo.71163}
}
EUVIMED